In addition to tumor samples, we also found that PKCθ was also highly expressed in the TNBC cell lines compared to the ER+ ones and it is present under its active form as reflected by the expression of phosphoThr-538 PKCθ [48,50]. The gene discussed is PRRT2; the disease is neoplasm.